agilon health (NYSE:AGL) Stock Price Up 3.6% – Should You Buy?

agilon health, inc. (NYSE:AGL) was up 3.6% during mid-day trading on Friday . The stock traded as high as $4.07 and last traded at $4.15. Approximately 533,432 shares changed hands during trading, a decline of 88% from the average daily volume of 4,608,505 shares. The stock had previously closed at $4.00.

Analyst Upgrades and Downgrades

AGL has been the subject of several research analyst reports. Sanford C. Bernstein raised their price objective on shares of agilon health from $2.50 to $3.15 and gave the stock a “market perform” rating in a report on Wednesday, January 15th. Macquarie started coverage on agilon health in a research note on Monday, December 16th. They issued a “neutral” rating and a $3.00 target price for the company. Needham & Company LLC reaffirmed a “hold” rating on shares of agilon health in a research note on Friday, March 21st. Stifel Nicolaus raised their price objective on agilon health from $2.00 to $3.00 and gave the company a “hold” rating in a research report on Wednesday, February 26th. Finally, Royal Bank of Canada boosted their target price on shares of agilon health from $3.00 to $3.50 and gave the company an “outperform” rating in a report on Wednesday, February 26th. Two research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and two have given a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $3.95.

agilon health Trading Up 3.4 %

The firm has a market capitalization of $1.70 billion, a PE ratio of -4.40 and a beta of 0.38. The firm has a 50 day simple moving average of $3.74 and a 200 day simple moving average of $3.00. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06.

Institutional Investors Weigh In On agilon health

Several large investors have recently bought and sold shares of the business. Capital International Investors boosted its holdings in shares of agilon health by 72.0% during the 4th quarter. Capital International Investors now owns 22,331,873 shares of the company’s stock valued at $42,431,000 after acquiring an additional 9,346,295 shares during the last quarter. Millennium Management LLC boosted its holdings in agilon health by 187.8% in the fourth quarter. Millennium Management LLC now owns 7,212,525 shares of the company’s stock worth $13,704,000 after purchasing an additional 4,706,357 shares during the last quarter. Algert Global LLC grew its position in agilon health by 1,042.7% in the 4th quarter. Algert Global LLC now owns 2,108,687 shares of the company’s stock worth $4,007,000 after purchasing an additional 1,924,157 shares during the period. Charles Schwab Investment Management Inc. raised its stake in agilon health by 49.2% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 4,541,549 shares of the company’s stock valued at $8,629,000 after buying an additional 1,498,524 shares during the last quarter. Finally, JPMorgan Chase & Co. lifted its holdings in shares of agilon health by 326.4% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company’s stock valued at $5,563,000 after buying an additional 1,083,492 shares during the period.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.